DE1251314B - - Google Patents

Info

Publication number
DE1251314B
DE1251314B DENDAT1251314D DE1251314DA DE1251314B DE 1251314 B DE1251314 B DE 1251314B DE NDAT1251314 D DENDAT1251314 D DE NDAT1251314D DE 1251314D A DE1251314D A DE 1251314DA DE 1251314 B DE1251314 B DE 1251314B
Authority
DE
Germany
Prior art keywords
acid
lactone
oxysteroid
mixture
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DENDAT1251314D
Other languages
German (de)
English (en)
Publication of DE1251314B publication Critical patent/DE1251314B/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
DENDAT1251314D Pending DE1251314B (cs)

Publications (1)

Publication Number Publication Date
DE1251314B true DE1251314B (cs)

Family

ID=604702

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1251314D Pending DE1251314B (cs)

Country Status (1)

Country Link
DE (1) DE1251314B (cs)

Similar Documents

Publication Publication Date Title
DE1152101B (de) Verfahren zur Herstellung von mit einem Pyrazolring kondensierten Steroidverbindungen
DE1251314B (cs)
DD144269A5 (de) Verfahren zur herstellung von steroidverbindungen
CH494216A (de) Verfahren zur Herstellung von in 3-Stellung einer verätherte Hydroxygruppe tragenden 6-Aminomethyl- 3,5-steroiden
DE1172671B (de) Verfahren zur Herstellung von 17ª‰-Hydroxy-androstan-(3, 2-c)-pyrazol oder eines 17ª‰-Hydroxy-17ª‡-niederes-Alkyl-androstan-(3, 2-c)-pyrazols
CH537913A (de) Verfahren zur Herstellung von 5(10)-Keto-19-nor-steroiden
DE1593501A1 (de) 15,16ss-Methylensteroide der 19-Nor-androstan-Reihe
DE1418945C3 (de) Verfahren zur Herstellung von 16 alpha Methyl 17alpha hydroxy 20 oxo pregnandenvaten
US2530389A (en) Adducts of bisnor-5, 7, 9(11)-cholatrien-22-al-3-one
EP0039893B1 (de) Verfahren zum Abbau der C-20-Carboxylgruppe in delta-4- und gegebenenfalls weitere Doppelbindungen enthaltenden BNC-Verbindungen sowie neue C-21-Steroide
DE1264441B (de) Verfahren zur Herstellung von 17alpha-AEthinyl-delta 5(10-19-nor-androsten-17beta-ol-3-on und 17alpha-AEthynil-19-nor-testosteron sowie dessen Estern
EP1163257B1 (de) Verfahren zur herstellung von 4,4- dimethyl -3beta- hydroxypregna -8,14-dien-21- carbonsäureestern und zwischenprodukte im verfahren
DE833961C (de) Verfahren zur Herstellung von Progesteron
DE1618747C3 (de) Verfahren zur Herstellung von Delta hoch 5(10) 3-Keto-19-nor-steroiden
CH500958A (de) Verfahren zur Herstellung von Steroidverbindungen
EP0000368B1 (de) D-Homosteroide und solche enthaltende Präparate sowie Verfahren zur Herstellung solcher D-Homosteroide
DE1668687A1 (de) Neue 18-Methyl-5alpha-H-androstane
DE948974C (de) Verfahren zur Herstellung von cyclischen 4-Halogenpregnan-3, 20-dion-3, 20-diketalen
AT257060B (de) Verfahren zur Herstellung von neuen 3-Enoläthern der 6-Methyl-3-oxo-Δ<4>-steroide der Androstan-, 19-Norandrostan-, Pregnan- und 19-Norpregnanreihe
CH505809A (de) Verfahren zur Herstellung 1(10)-5-oxo-5,10-Seco-steroiden
WO1998004579A1 (de) Verfahren zur herstellung von 3-sulfanato-oxy-estra-1,3,5(10)-trien-derivaten ii
DE2001262A1 (de) 19-Homosteroide
DE1164402B (de) Verfahren zur Einfuehrung einer Sauerstofffunktion in Steroide
DE2508110A1 (de) Verfahren zur gewinnung von 19-nor-delta hoch 4 -androsten-3,17- dion
DE1418856A1 (de) Steroide und Verfahren zu ihrer Herstellung